Pharsight

Drugs that contain Melphalan Hydrochloride

1. Evomela patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9200088 ACROTECH Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US8410077 ACROTECH Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US11020363 ACROTECH Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
May, 2030

(6 years from now)

US10864183 ACROTECH Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
May, 2030

(6 years from now)

US10940128 ACROTECH Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
Jun, 2030

(6 years from now)

US9493582 ACROTECH Alkylated cyclodextrin compositions and processes for preparing and using the same
Feb, 2033

(8 years from now)

US10040872 ACROTECH Alkylated cyclodextrin compositions and processes for preparing and using the same
Jan, 2034

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Mar 10, 2023

Market Authorisation Date: 10 March, 2016

Treatment: For high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma

Dosage: POWDER;INTRAVENOUS

How can I launch a generic of EVOMELA before it's drug patent expiration?
More Information on Dosage

EVOMELA family patents

Family Patents

2. Hepzato patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10098997 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Nov, 2032

(8 years from now)

US11633528 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Nov, 2032

(8 years from now)

US10369264 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Nov, 2032

(8 years from now)

US11241522 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Nov, 2032

(8 years from now)

US10569004 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Nov, 2032

(8 years from now)

US11083831 DELCATH SYSTEMS INC Filter and frame apparatus and method of use
Dec, 2032

(8 years from now)

US11833286 DELCATH SYSTEMS INC Filter and frame apparatus and method of use
Dec, 2032

(8 years from now)

US10195334 DELCATH SYSTEMS INC Filter and frame apparatus and method of use
Jan, 2033

(8 years from now)

US9314561 DELCATH SYSTEMS INC Filter and frame apparatus and method of use
Feb, 2034

(9 years from now)

US9707331 DELCATH SYSTEMS INC Apparatus for removing chemotherapy compounds from blood
Sep, 2034

(10 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Aug 14, 2026
Orphan Drug Exclusivity (ODE) Aug 14, 2030

Market Authorisation Date: 14 August, 2023

Treatment: A percutaneous hepatic perfusion procedure for treating a patient with uveal melanoma with unresectable hepatic metastases; A method for treating a subject with uveal melanoma with unresectable hepati...

Dosage: POWDER;INTRA-ARTERIAL

More Information on Dosage

HEPZATO family patents

Family Patents

3. Melphalan Hydrochloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537520 APOTEX Stable liquid formulations of melphalan
Jun, 2036

(12 years from now)

Market Authorisation Date: 18 August, 2023

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

MELPHALAN HYDROCHLORIDE family patents

Family Patents